iTeos Therapeutics (ITOS) Insider Trading & Ownership $8.31 -0.24 (-2.81%) (As of 11:57 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends iTeos Therapeutics (NASDAQ:ITOS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$38,650.00Number OfInsiders Selling(Last 12 Months)0 Get ITOS Insider Trade Alerts Want to know when executives and insiders are buying or selling iTeos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITOS Insider Buying and Selling by Quarter Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. iTeos Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/19/2024Matthew GallCFOBuy5,000$7.73$38,650.00 (Data available from 1/1/2013 forward) ITOS Insider Trading Activity - Frequently Asked Questions Who is on iTeos Therapeutics's Insider Roster? The list of insiders at iTeos Therapeutics includes Aaron I Davis, Bioventures 2018 L.P. Mpm, Boxer Capital, Llc, David Hallal, Detlev Biniszkiewicz, Joanne Jenkins Lager, Matthew Gall, Michel Detheux, and Yvonne Mcgrath. Learn more on insiders at ITOS. What percentage of iTeos Therapeutics stock is owned by insiders? 12.50% of iTeos Therapeutics stock is owned by insiders. Learn more on ITOS's insider holdings. Which iTeos Therapeutics insiders have been buying company stock? The following insider purchased ITOS shares in the last 24 months: Matthew Gall ($80,500.00). How much insider buying is happening at iTeos Therapeutics? Insiders have purchased a total of 10,000 ITOS shares in the last 24 months for a total of $80,500.00 bought. Which iTeos Therapeutics insiders have been selling company stock? The following insider sold ITOS shares in the last 24 months: Boxer Capital, Llc ($5,691,000.00). How much insider selling is happening at iTeos Therapeutics? Insiders have sold a total of 350,000 iTeos Therapeutics shares in the last 24 months for a total of $5,691,000.00 sold. iTeos Therapeutics Key ExecutivesDr. Michel Detheux Ph.D. (Age 57)President, CEO & Director Compensation: $1.04MMr. Matthew Gall (Age 47)Chief Financial Officer Compensation: $648k1 recent tradesMr. Matthew A. Call M.B.A. (Age 51)Chief Operating Officer Compensation: $706.21kDr. Yvonne McGrath Ph.D. (Age 50)Chief Scientific Officer Ms. Adi OsovskyExecutive Vice President of LegalMr. Philippe BrantegemExecutive Vice President of Human ResourcesDr. Joyson Joseph Karakunnel FACP (Age 53)M.D., M.Sc., Interim Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ANIP Insider Trading SEPN Insider Trading GYRE Insider Trading AVDL Insider Trading BCAX Insider Trading COGT Insider Trading ETNB Insider Trading NUVB Insider Trading COLL Insider Trading ZYME Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024?Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in Buybacks This page (NASDAQ:ITOS) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
